AR30 — Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

AR30 — Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing. · Informed CitizenryThis resolution urges the U.S. Food and Drug Administration (FDA) to reconsider its approval of Zohydro ER, a long-acting formulation of the opioid hydrocodone, pending comprehensive testing. The r…Open in Informed Citizenry